Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

iRFP-C1 Citations (3)

Originally described in: Bright and stable near-infrared fluorescent protein for in vivo imaging.
Filonov GS, Piatkevich KD, Ting LM, Zhang J, Kim K, Verkhusha VV Nat Biotechnol. 2011 Jul 17. doi: 10.1038/nbt.1918.
PubMed Journal

Articles Citing iRFP-C1

Articles
Polo-like Kinase 1 Inhibition as a Therapeutic Approach to Selectively Target BRCA1-Deficient Cancer Cells by Synthetic Lethality Induction. Carbajosa S, Pansa MF, Paviolo NS, Castellaro AM, Andino DL, Nigra AD, Garcia IA, Racca AC, Rodriguez-Berdini L, Angiolini V, Guantay L, Villafanez F, Federico MB, Rodriguez-Baili MC, Caputto BL, Drewes G, Madauss KP, Gloger I, Fernandez E, Gil GA, Bocco JL, Gottifredi V, Soria G. Clin Cancer Res. 2019 Jul 1;25(13):4049-4062. doi: 10.1158/1078-0432.CCR-18-3516. Epub 2019 Mar 19. PubMed
Vasodilator-stimulated phosphoprotein (VASP) is recruited into dendritic spines via G-actin-dependent mechanism and contributes to spine enlargement and stabilization. Iwasaki K, Obashi K, Okabe S. Eur J Neurosci. 2020 Feb;51(3):806-821. doi: 10.1111/ejn.14634. Epub 2019 Dec 18. PubMed
Spatiotemporal control of phosphatidic acid signaling with optogenetic, engineered phospholipase Ds. Tei R, Baskin JM. J Cell Biol. 2020 Mar 2;219(3). pii: 133675. doi: 10.1083/jcb.201907013. PubMed

Associated Plasmids

If you have published an article using this material, please email us at [email protected] to have your article added to this page.